T-Cell Molecular Modulation Responses in Atherosclerosis Anergy

Area of Science:

• Immunology
• Cardiovascular Research
• Molecular Biology

Background:

• Atherosclerosis remains a leading cause of death globally, associated with cardiovascular diseases.
• The role of the immune system, particularly adaptive T cell responses, in atherosclerotic plaque inflammation is increasingly recognized.

Purpose of the Study:

• To review the involvement of T cells in atherosclerosis-mediated inflammation.
• To explore potential therapeutic strategies for ameliorating atherosclerosis complications through immunomodulation.

Main Methods:

• Review of current literature on T cell subsets, cytokines, and microRNAs in atherosclerosis.
• Analysis of growth factor/receptor axes and their impact on the atherosclerotic inflammatory cycle.

Main Results:

• T-lymphocyte subsets, microRNAs (miRs), and growth factor/receptor interactions significantly affect the inflammatory cycle of atherosclerosis.
• Manipulation of miRNA expression and growth factor receptors shows promise as diagnostic biomarkers for inducing anergy and blocking disease progression.

Conclusions:

• T cell-mediated immune responses play a critical role in the pathogenesis of atherosclerosis.
• Targeting T cell responses, microRNAs, and specific growth factor pathways presents viable therapeutic avenues for managing atherosclerosis and its complications.